Remove 2004 Remove Compliance Remove Hospitals Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

726/2004, 09 March 2021. 726/2004 , which essentially means duplicate MAAs for products authorized via the centralized procedure. These missions will allow the Commission to identify, and, if necessary, correct any non-compliance or weaknesses. World Health Organization (WHO).

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

While preparing the patient’s compliance pack, the pharmacy misinterpreted the product to contain 500 mg of Calcium Carbonate when each tablet actually contained 500 mg of elemental Calcium. times the intended dose and required intervention in a hospital. As a result, the patient received 2.5

FDA 40